The recent emergence of avian pneumovirus (APV) infection among US turkey flocks has resulted in a major economic threat to the turkey industry. In order to elucidate the molecular epidemiology of APV, comparative sequence analysis of the fusion (F) protein gene of APV was performed for 3 cell cultureadapted isolates and 10 APV positive clinical samples recovered from US turkey flocks. Relatively modest levels of nucleotide and amino acid sequence divergence were identified, suggesting the prevalence of a single lineage of APV among US turkey flocks. Additionally, numerous polymorphisms were identified that were only represented in the clinical samples but not in the in vitro propagated isolates of APV. Phylogenetic analyses confirm that the subtype of APV circulating in the upper Midwestern United States is evolutionarily related to, but distinct from, European APV subgroups A and B. Overall, the results of the present investigation suggest that there has been only a single recent introduction of APV into US turkey populations in the upper Midwestern United States.
A novel avian pneumovirus (APV) emerged as an avian respiratory pathogen in the United States during 1996 17 and is now recognized as a predominant respiratory pathogen in turkey flocks of the north central United States. Since its initial description in Minnesota turkey flocks, APV outbreaks are observed throughout the year, and the virus is considered endemic to the region. 3 Preliminary studies of the epizootiology of APV infections and disease transmission in individual turkey farms and flocks indicate that prior APV infection in a flock does not necessarily prevent the occurrence of subsequent outbreaks. It is tempting to speculate that this lack of protection results from genomic and antigenic variations, especially those resulting in changes in the antigenic epitopes of APV that are recognized by the immune system. This phenomenon has been previously proposed as the reason for reoccurrence of pneumoviral infections in previously infected hosts. 8 Genetic characterization of the matrix (M) and fusion (F) protein genes of the Colorado isolate (APV/ CO) and two Minnesota isolates (APV/MN-1a and APV/MN-1b) indicates that APV/US is phylogenetically related to, but distinct from, subgroups A and B of APV reported in Europe. [1] [2] [3] [15] [16] [17] The degree of heterogeneity among the F protein genes of the 3 laboratory-adapted isolates of APV/US (APV/CO, APV/ MN-1a, and APV/MN-1b) was found to be limited at 0.2%. 15, 16 To date, studies examining sequence varia-tion in genes from the US subtype of APV have been based on cell culture-adapted APV isolates. 15, 16 A potential limitation of indexing variation only on cell culture-adapted isolates is that the samples are biased (based on ability to grow in cell culture), and interpretation of the results may be further complicated by the presence of sequence variation resulting from in vitro propagation and adaptation. Consistent with this fact, studies from our laboratories have identified nucleotide substitutions in the N and P genes of non-cell culture-adapted clinical samples but not in cell cultureadapted isolates of APV. 1 Understanding the molecular epidemiology and the degree of genetic variation among APV/US is essential for designing effective diagnostic and control strategies. The F protein is considered to be the most immunogenic antigen of pneumoviruses. 5 Hence, information on F gene sequence variation among natural isolates of APV will not only enhance the current understanding of the molecular epidemiology of this virus, but will also have significant implications in the development of protective vaccines. To this end, comparative sequence and phylogenetic analyses were carried out on the F gene of the 3 cell culture-adapted APV isolates (APV/CO, APV/MN-1a, and APV/MN-1b) and 10 APV-positive clinical samples (not adapted in cell culture) obtained from turkey flocks in the upper Midwestern United States.
Materials and methods
Cells and viruses. The APV/CO isolate was obtained from the National Veterinary Services Laboratories (NVSL), Ames, Iowa, and has been previously described. 17 APV/MN-1a and APV/MN-1b were initially isolated and maintained in our laboratory. 3 Ten clinical samples (tracheal/esophageal Table 1 . All 10 clinical samples were positive for APV as detected by reverse transcription-polymerase chain reaction (RT-PCR 2 ). The APV isolates were propagated in Vero cells cultured in Eagle minimum essential medium a supplemented with 4% fetal bovine serum and antibiotics (penicillin 200 units/ml, streptomycin 200 g/ml, gentamicin 50 g/ml, neomycin 150 g/ml, and fungizol 1 g/ ml). Viral isolates were purified by sucrose gradient centrifugation 14 and stored at Ϫ80 C until further use. RNA isolation and RT-PCR. Total RNA was extracted from purified virus isolates, noninfected Vero cells, and clinical samples using a QIAamp viral RNA extraction kit. b Viral RNA was subjected to RT-PCR using primers designed from the previously described F gene of APV/CO. 2, 16 Sequence analysis. PCR products were either directly sequenced in both orientations or were sequenced after cloning into pGEM-T plasmid vector. c All sequence reactions were performed at the University of Minnesota's Advanced Genetic Analysis Center (AGAC) using ABI 377 automated DNA sequencers. d The DNA sequences were assembled and analyzed with EDITSEQ, MEGALIGN, and SEQMAN computer programs. e Phylogenetic analysis of the aligned sequences was performed with PAUP 4.02b. 20 The number of synonymous changes per synonymous site (d s ) and coding changes per nonsynonymous site (d n ) in coding regions of the F gene were calculated by the unweighted method of Nei and Gojobori. 12 The dendrogram was constructed using the nearestneighbor interchange (NNI) option with branch swapping and 1,000 bootstrap replications.
Results
As described previously for the US subtype of APV, 2,16 the F gene from all APV clinical samples was found to be 1,646 bases in length with a single large open reading frame (ORF) from position 14 to 1,628 encoding a polypeptide of 537 amino acid (AA) residues with a predicted molecular mass of 58 kDa.
The putative gene start (GS) signal of the F gene from 7 clinical samples (5Ј-GGGACAAGT) was similar to that in APV subgroup A and APV/CO, APV/ MN-1a, and APV/MN-1b isolates. 2, 16 However, GS signal sequence of 3 clinical samples (8, 17, and 18) showed a slightly different GS signal (5Ј-GGGA-CAAAT) with a single nucleotide substitution (a transition) at position 8 ( Table 2 ). While the significance of this substitution in the 3Ј untranslated region (UTR) (negative sense RNA) of the F gene is presently unknown and must await further biological characterization, it is noteworthy that similar alterations in other negative-stranded RNA viruses have been found to have a profound effect on the expression of the affected gene. 7 Consistent with the possibility of selective pressure and bias during the in vitro propagation of APV, a nucleotide substitution at position 1,637 in the 5Ј UTR (negative sense RNA) was present in all of the clinical samples but not in the 3 laboratory-adapted isolates. The exact significance and role of the presence of this particular substitution in clinical samples but not in the laboratory-adapted isolates is presently unknown.
The alignment of the F gene nucleotide sequences from APV/MN-1a and APV/MN-1b isolates showed 2 substitutions in APV/MN-1a and APV/MN-1b when compared with APV/CO at nucleotide positions 976 and 1,385. The substitution at location 1,385 was nonsynonymous and resulted in a conservative (I ↔ V) amino acid replacement at residue 475. In contrast, the nucleotide sequence of the F gene from clinical samples showed 10-12 nucleotide substitutions (when compared with APV/CO) ( Table 2) . Interestingly, 6 of these substitutions were nonsynonymous in nature ( Table 2 ). This relatively higher number of nonsynonymous substitutions (6 of 13 [46%]) might be suggestive of functional or immunologic pressure that has been acting to promote changes in the primary structure of the F protein. It is interesting to note, however, that the previously described immunodominant (F2) region of the F gene 13 from all 10 clinical samples showed only 1 synonymous substitution at nucleotide position 61; all other substitutions were in the F1 region of the predicted protein ( Fig. 1) . Point mutations in nucleotide sequence are classified as transitions or transversions, depending on the nature of the change. Transition comprises substitution of 1 pyrimidine by the other or of 1 purine by the other. Transversion is the point mutation in which a purine is replaced by a pyrimidine or vice versa. The nucleotide substitutions in the F gene of clinical samples were point mutations, the majority of which were transitions as compared with transversions. Further, twice as many G ↔ A transitions were noted as compared with C ↔ U transitions. This finding is similar to that described for the G gene of subgroup A human respiratory syncytial virus (HRSV), which has 3 times more G ↔ A than C ↔ U transitions. 9 While the bias toward G ↔ A transition in the G gene of HRSV is thought to be related to the hypermutation events occurring during selection process in vivo and not as a result of accumulative misincorporation of nucleotides during viral replication, 9, 10 its provenance in the case of APV isolates is not presently known.
Only 0.2% amino acid sequence divergence was seen among the 3 isolates. However, the F gene sequences from clinical samples showed 0.9-1.1% and 0.9-1.3% amino acid sequence divergence from APV/ CO and APV/MN-1a, APV/MN-1b isolates, respectively. These data also suggest that the in vitro propagation of APV may result in selective pressure and therefore an underrepresentation of the true level of genetic variation that is present in natural isolates of the virus and highlights the importance of indexing nucleotide diversity in both clinical samples and culture-adapted isolates.
The signal peptide and the transmembrane region have been reported to be the most variable domains in the F gene of APVs. 2, 11, 16 For instance, the signal peptide and transmembrane domains of APV/US F protein show ϳ33 and ϳ37% amino acid sequence identity to the corresponding regions of APV subgroup A and 28 and 26% identity to the corresponding regions in APV subgroup B, respectively. 2, 11, 16 Consistent with this observation, the signal peptide and transmembrane regions of the F protein from the 10 clinical samples characterized during our investigation showed ϳ98 and ϳ95% amino acid sequence identity to the corresponding regions in APV/CO and APV/MN-1a, APV/MN-1b isolates, respectively.
The analysis of total nucleotide diversity () shows minimal levels of nucleotide polymorphism (0.001 Ϯ 0.0009) among the 3 cell culture-adapted APV isolates. In contrast, the clinical samples showed a slightly higher level of nucleotide diversity (0.005 Ϯ 0.002 to 0.007 Ϯ 0.002) when compared with APV/CO. The D n /D s ratio between the F gene of APV/CO and APV/ MN-1a was 0.33 and was comparable with the D n /D s ratio (0.3-0.4) between APV/CO and clinical samples. Because the D n /D s ratios were considerably less than 1, it is likely that purifying selection is acting to maintain the primary structure of the F protein in APV/US isolates. 6 Phylogenetic analysis of the F-gene sequence of APV using parsimony with mammalian pneumoviruses as outgroup confirms previous findings 1,2,16 that APVs can be grouped into 3 distinct clusters, represented by APV/US (APV subgroup C), APV subgroup A, and APV subgroup B viruses (Fig. 2a, 2b ). This clustering was statistically supported by 99-100% bootstrap replicates (Fig. 2a) . The F gene of APV/US isolates showed the distinct grouping of APV/MN-1a, APV/MN-1b and APV/CO isolates as a single branch with support of 86% of 1,000 bootstrap replicates and the grouping of field virus (without in vitro propagation) as a separate branch supported by 67% of 1,000 bootstrap replicates ( Fig. 2a ).
Discussion
The control of infectious diseases is one of the most important issues in human or veterinary medicine. In particular, emerging viral infections pose a special challenge due to lack of satisfactory methods for diagnosis, prevention, and control. An understanding of the molecular epidemiology and overall genetic variation among these emerging viruses provides a framework for the rational development of diagnostic tests and vaccines and the design of strategies to control these diseases. It has recently been reported 19 that substantial intrasubtype genetic heterogeneity of pneumoviruses and circulation of discrete genetic lineages in a single epidemic are not uncommon. The results reported in the present investigation based on surface glycoprotein F gene suggest limited levels of heterogeneity among the F gene sequences of APV/US recovered from various APV-infected turkey flocks over a 5-month period and those of the 3 APV isolates recovered nearly a year earlier. These results are in agreement with the previous findings based on laboratory-adapted isolates, 16 suggesting limited genetic heterogeneity among US isolates of APV and supporting the hypothesis that there is a single distinct genetic lineage of APV circulating among US turkey flocks. Further, the data presented here confirm previous findings that the US APVs are phylogenetically related to, but distinct from, their European counterparts and constitute a third subgroup (subgroup C) of APV. 1, 2, 15, 16 The results of our studies also highlight the fact that there are considerable differences in the distribution and levels of nucleotide substitutions in the F gene of APV isolates compared with clinical samples. The role and biological significance of these differences must await further investigations.
APV subgroup C has emerged relatively recently in US turkey flocks and is currently endemic in the upper Midwestern United States. Phylogenetic analyses of N, P, M, F, and M2 genes suggest that subgroup C is quite distinct from subgroups A and B. 1, 2 The reasons and sources for the emergence of APV C in the United States decades after the description of subgroups A and B in Africa and Europe remain unknown. There are 2 major hypotheses regarding the provenance and recent emergence of APV subgroup C in domestic poultry. The first hypothesis is that APV subgroup C, while only recently discovered in domestic poultry, is an old virus with a feral reservoir, most likely in wild migratory birds, that has recently become adapted to domestic poultry. Two observations support this hypothesis: a) the virus emerged in relatively close temporal succession in 2 widely separated locations, Colorado and Minnesota, both of which are on a common wild bird and waterfowl migratory route. b) Recent observations suggest that the virus can be recovered from wild bird populations trapped in close proximity to domestic poultry barns. 18 The second and more intriguing anthropozoonotic hypothesis suggests that APV subgroup C was transferred to domestic poultry from humans, where a related virus is endemic. Consistent with this hypothesis, a human pneumovirus (named human metapneumovirus) has recently been isolated and shares considerable homology with isolates of APV subgroup C. 4 Analysis of serum samples suggests that this human metapneumovirus has circulated in the human population for at least the past 5 decades. Interestingly, while it is not possible to determine which of these 2 alternate scenarios is true, both hypotheses, especially the former, predict that the future emergence of novel APVs in domesticated poultry should be anticipated.
